Sign In
Buy AKRX
$0.0900
+0 (+0%)
At Close: Sep 04, 2020
Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Gel, 0.5%
09:10am, Thursday, 11'th Feb 2021
LAKE FOREST, Ill., Feb. 11, 2021 /PRNewswire/ -- Akorn Operating Company LLC (Akorn), a leading specialty pharmaceutical company, announced that it received approval of its Abbreviated New Drug Applic
Akorn, Inc. (NASDAQ:AKRX) Shares Sold by BlackRock Inc.
04:02am, Wednesday, 10'th Jun 2020
BlackRock Inc. cut its position in shares of Akorn, Inc. (NASDAQ:AKRX) by 2.2% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutio
Akorn to Acquire VersaPharm for $440 Million
09:18am, Friday, 09'th May 2014
LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX) today announced that it has entered into a definitive agreement to acquire VPI Holdings Corp., the parent company of VersaPharm Incorpora
Akorn Reports 2014 First Quarter Results
07:00am, Tuesday, 06'th May 2014
LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the first quarter ended March 31, 2014. First Quarter 2014
Akorn Reports 2013 Fourth Quarter and Year-End Financial Results
06:00am, Monday, 03'rd Mar 2014
LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the fourth quarter and year-ended December 31, 2013. Raj Ra
